PCR

Alercell to Distribute Amoy Diagnostic Ros1 Gene Fusion Detection Kit in US

MiRxes, Singapore Healthcare Organizations Partner to Develop Multi-Cancer Early Detection Test

Precipio Receives CE-IVD Mark for Hematologic Cancer Panels

Qiagen Gets CE Mark for Therascreen EGFR Plus RGQ Kit for Non-Small Cell Lung Cancer

Alercell to Distribute Zeesan Biotech Leukemia Fusion Gene Test Kit

InnoSign Raises $8M in Series A Financing, Spins off From Royal Philips

Cerca Biotech Inks European Distribution Deals for MammaTyper Breast Cancer Subtyping Test

Biocartis, Ophiomics Partner to Commercialize Gene Expression Prognostic Test for Liver Cancer

Mainz Biomed Plans Study to Evaluate mRNA Biomarkers for Colorectal Cancer

DiaCarta to Explore XNA Clamp Tech for Low-Frequency Mutations Under NIH Collaboration

Nucleix Raises Additional $22M

Qiagen, Denovo Biopharma to Develop Liquid Biopsy CDx Test for Investigational Lymphoma Treatment

Cancer Dx Firms ACT Genomics, Sanomics Merge

Saga Diagnostics, AstraZeneca Ink Digital PCR Assay Development Deal

Amoy Diagnostics, Amgen Partner on Lung Cancer CDx Development for Lumakras in Japan

Amoy Diagnostics CDx Gets Japanese Approval to ID NSCLC Patients Eligible for Tepmetko

Promega, Henlius to Develop Microsatellite Instability CDx for Cancer Drug

FDA Clears Promega Microsatellite Instability Test System